Stocks in Play

Valneva SE

09:52 AM EST - Valneva SE : Announced positive initial booster data and final Phase 1 data for its leading, unique Lyme disease vaccine candidate VLA15. Valneva SE shares V.VLA are trading unchanged at $0.30.